Walkner Condon Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Buy
1,536
+71
+5% +$72.5K 0.21% 85
2026
Q1
$1.35M Buy
1,465
+14
+1% +$14.2K 0.18% 102
2025
Q4
$1.56M Buy
1,451
+111
+8% +$106K 0.22% 90
2025
Q3
$1.02M Buy
1,340
+446
+50% +$332K 0.16% 108
2025
Q2
$697K Buy
894
+19
+2% +$14.8K 0.13% 124
2025
Q1
$723K Buy
875
+77
+10% +$64.1K 0.15% 114
2024
Q4
$616K Sell
798
-137
-15% -$113K 0.13% 137
2024
Q3
$828K Buy
935
+138
+17% +$124K 0.17% 107
2024
Q2
$720K Buy
797
+61
+8% +$48.8K 0.16% 110
2024
Q1
$573K Buy
736
+104
+16% +$74K 0.12% 139
2023
Q4
$368K Buy
632
+11
+2% +$6.42K 0.08% 185
2023
Q3
$334K Buy
621
+17
+3% +$8.76K 0.09% 174
2023
Q2
$283K Buy
604
+11
+2% +$4.61K 0.08% 193
2023
Q1
$204K Buy
+593
New +$200K 0.06% 227
2022
Q1
Sell
-1,387
Closed -$383K 218
2021
Q4
$383K Sell
1,387
-8
-0.6% -$2.03K 0.25% 88
2021
Q3
$322K Hold
1,395
0.16% 113
2021
Q2
$320K Hold
1,395
0.12% 130
2021
Q1
$261K Sell
1,395
-98
-7% -$19.2K 0.1% 145
2020
Q4
$252K Buy
1,493
+129
+9% +$19.3K 0.11% 115
2020
Q3
$202K Buy
+1,364
New +$211K 0.11% 120

Other funds holding LLY

Walkner Condon Financial Advisors's LLY Position: Q2 2026 in Review

Walkner Condon Financial Advisors increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $72.5K and bringing the position to 1,536 shares worth $1.84M. The position accounts for 0.21% of the portfolio, ranked #85.

Walkner Condon Financial Advisors first reported a position in LLY in Q3 2020 and has held it in 20 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Walkner Condon Financial Advisors held 1,536 shares of Eli Lilly worth $1.84M as of Q2 2026.
  • Walkner Condon Financial Advisors bought 71 Eli Lilly shares in Q2 2026, an estimated $72.5K.
  • Eli Lilly made up 0.21% of Walkner Condon Financial Advisors's portfolio in Q2 2026, its #85 holding.
  • Walkner Condon Financial Advisors first reported a position in Eli Lilly in Q3 2020 and has held it in 20 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Walkner Condon Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.